Soligenix, Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery

Other Names/Subsidiaries

  • Biological Therapeutics, Inc.
  • DOR BioPharma, Inc.
  • Endorex Corporation
  • Enteron Pharmaceuticals
  • Immunotherapeutics Inc.
See more in Biomedtracker

Latest on Soligenix, Inc.

In Vivo

Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else

 
• By Bridget Silverman

A beneficial effect of sponsorship by the largest companies in the pharma industry can be seen in the fates of novel agent applications that faced US FDA approval decisions in recent years: the applic

Pink Sheet

Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else

 
• By Bridget Silverman

A beneficial effect of sponsorship by the largest companies in the pharma industry can be seen in the fates of novel agent applications that faced US FDA approval decisions in recent years: the applic

Scrip

Deal Watch: Dianthus Will Reach Public Markets Via Reverse Merger With Stalled-Out Magenta

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Newly Public Dianthus Projects Financia

Pink Sheet

Keeping Track: Travere’s Filspari, Chiesi’s Lamzede, Apellis’ Syfovre Headline US FDA Approvals; CRLs For Phathom, Biocon

 
• By Bridget Silverman

The US Food and Drug Administration closed out last week with the approvals of two novel agents for rare diseases, Travere Therapeutics, Inc. 's Filspari for IgA nephropathy and Chiesi Global Rare Di